Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Diabetes Insipidus × Arginine × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Prostatic Neoplasms 2 Neoplasms 2 Malnutrition 2 Head and Neck Neoplasms 2 Colorectal Neoplasms 2 Thrombosis 1 Stomach Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Sexuality 1 Sexual Dysfunction, Physiological 1 Salivary Gland Neoplasms 1 Radiation Injuries 1 Protein Metabolism 1 Polycystic Ovary Syndrome 1 Pain 1 Neuroendocrine Tumors 1 Neoplasm Metastasis 1 Multiple Endocrine Neoplasia Type 1 1 Mucositis 1 Meningioma 1 Hemorrhage 1 Glioblastoma 1 Erectile Dysfunction 1 Disease 1 Diabetes Insipidus 1 Brain Neoplasms 1

Interventions

Vasopressins 3 carbetocin 1 Tourniquets 1 Terlipressin 1 Surgical Procedures, Operative 1 Spinal Puncture 1 Specimen Handling 1 Radiotherapy, Intensity-Modulated 1 Radiotherapy, Conformal 1 Oxytocin 1 Misoprostol 1 Magnetic Resonance Spectroscopy 1 Etoposide 1 Ethamsylate 1 Carboplatin 1 Bupivacaine 1 Arginine Vasopressin 1 Arginine 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT05293041 2025-03-06

ARG-01

Sahlgrenska University Hospital

Phase 4 Completed

Diabetes Insipidus, Hemorrhage, Pain, Thrombosis

Data powered by HemOnc (CC BY 4.0) Colophon ⚡